Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
A Randomized Trial of Interventions for Teenage Drivers With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In Buffalo
A Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD), Part I
This study has finished and is no longer accepting participants.
In San FranciscoThis study evaluates the safety and effectiveness of SPD465 for people with ADHD.
This study was withdrawn before enrollment.
In TampaResearchers compared Guanfacine hydrochloride (TAK-503), Atomoxetine hydrochloride and placebo, tracking side effects to assess safety in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanA Phase 2 Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Proof-of-Concept Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Multiple locations, including Bradenton
Healthcare Resources Utilization and Associated Costs of Adult ADHD in England
This study has finished and is no longer accepting participants.
In LondonResearchers compared dasotraline 4mg and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachResearchers compared dasotraline and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachResearchers compared PF-03654746 and placebo, tracking side effects to assess safety in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including LafayetteProspective Follow-Up Observational Study to Examine the Progression of ADHD Drug Treatment and to Analyze Associated Factors
This study has finished and is no longer accepting participants.
Multiple locations, including Bucheon-Si Gyeonggi-DoResearchers compared MK0249, Concerta (methylphenidate) and placebo, tracking side effects to assess safety in adults with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.